Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Category: Pharma applications

February 27, 2026 Drug delivery / Pharma applications

5th International Conference Integrative Chemistry, Biology & Translational Medicine

The conference will be held on 25-27 June 2026 in Debrecen. The journey of ICBTM began in 2019 with the

Continue reading

February 26, 2026 CD derivatives / Drug delivery / Pharma applications

Cyclodextrin Polymer Complexation Improves the Tolerability of Parenteral Oestradiol

This study investigates the PEG‑β‑CD polymer, a water‑soluble polyethylene glycol–β‑cyclodextrin cross‑linked carrier, as a potential alternative to conventional oestradiol formulations

Continue reading

February 23, 2026 CD as API / Pharma applications

The mechanism of ototoxicity studied by using HPBCD

The cochlea is the sensory organ responsible for hearing. Central to its sensory functions is the organ of Corti, a

Continue reading

February 19, 2026 CD as API / Drug delivery / Pharma applications

Enhancing the Water Solubility and Efficacy of Anticancer Drugs Using Hydroxypropyl-β-Cyclodextrin

Previous studies have demonstrated that the solubility and biocompatibility of poorly water-soluble anti-cancer agents can be improved by complexation with

Continue reading

February 18, 2026 Drug delivery / Pharma applications

Dimethylated β-cyclodextrin inclusion complexes containing the guest steroid hormones progesterone and 17β-estradiol: syntheses, crystal structures, thermal analyses and steroid solubility enhancements

The aim of the present study was to complex the potent steroidal hormones progesterone (PRO) and 17β-estradiol (BES) with heptakis(2,6-di-O-methyl)-β-cyclodextrin

Continue reading

February 17, 2026 CD derivatives / Drug delivery / Pharma applications

New FDA approved medicinal product containing Betadex sulfobutylether sodium: VYKOURA

VYKOURA is a newly approved medication (marketing start date: 02/03/2026) containing leucovorin calcium, a prescription injectable drug used in hospital

Continue reading

a rat is standing on top of a plastic container
February 12, 2026 CD derivatives / Drug delivery / Life sciences / Pharma applications

Betadex sulfobutylether sodium — a key enabler for potent neurotherapeutics

In the search for better therapies for neurodegenerative diseases like Parkinson’s, researchers are increasingly looking beyond classical drugs to the

Continue reading

February 10, 2026 CD derivatives / Drug delivery / Pharma applications

Sulfated β-Cyclodextrin-Mediated Antimicrobial Peptide Nanoparticles for Alkaloid Encapsulation

The β-cyclodextrin bearing an average of 13 sulfate groups (S13βCD) uniquely combines two key functions: it binds pharmaceutically relevant alkaloids

Continue reading

February 9, 2026 CD as API / Drug delivery / Pharma applications

CDs for Regulating Cholesterol Homeostasis in Atherosclerosis

The progression of atherosclerosis (AS) is strongly linked to lipid crystals accumulation caused by cholesterol metabolism disorders and the worsening

Continue reading

February 5, 2026 Drug delivery / Pharma applications

Remdesivir (GS-5734) protects African green monkeys (AGM) from Nipah virus challenge

Introduction: Nipah virus is an emerging pathogen in the Paramyxoviridae family, which appers today a real threat for eventual pandemy.

Continue reading

Posts pagination

«Previous Posts 1 2 3 4 5 … 125 Next Posts»

Recent Posts

  • HPβCD’s Promise in Treating Ischemic Stroke
  • Surface-Engineered Amino-Graphene Oxide Aerogel Functionalized with Cyclodextrin for Desulfurization and Denitrogenation in Oil Refining
  • Cyclodextrin and KR12-Lipopeptide Interactions
  • Comparative study of thiolated and alkenylated functionalized β-CDs as highly mucopenetrating and mucoadhesive drug delivery systems.
  • Phosphorylated Beta-cyclodextrin as a New Bone-Targeting Drug Delivery System Could Change the Treatment of Osteoporosis and Other Bone Diseases

Tags

alpha-CD Alzheimer disease atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (26)
  • Analysis (63)
  • CD as API (340)
  • CD derivatives (395)
  • Cosmetics and toilettry (49)
  • Diagnosis (11)
  • Drug delivery (774)
  • E-ducation (63)
  • Environmental (129)
  • Events (232)
  • Food (217)
  • Gene delivery (19)
  • Household products (4)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (42)
  • Non-pharma applications (390)
  • Other industrial use (104)
  • Pharma applications (1,157)
  • Supramolecular systems (40)
  • Uncategorized (140)

Top Posts

  • Oculis: eye drops with Dexamethasone/gamma-CD complex Phase 3 study concluded soon
  • HPβCD's Promise in Treating Ischemic Stroke
  • Lanosterol eye drops for cataract treatment
  • Flame-Resistant 3D Printing with Cyclodextrin: A Hewlett-Packard Patent Application
  • Sun-protective clothing using benzophenone/CD complex
  • Arthur Lütringhaus, Godfather of catenanes was born 120 years ago
  • Phosphorylated Beta-cyclodextrin as a New Bone-Targeting Drug Delivery System Could Change the Treatment of Osteoporosis and Other Bone Diseases
  • Surface-Engineered Amino-Graphene Oxide Aerogel Functionalized with Cyclodextrin for Desulfurization and Denitrogenation in Oil Refining
  • Minimizing tissue reactions with cyclodextrins at infusion site of insulin therapy
  • Does Vinblastine Retain its Anticancer Effect in the Presence of Cyclodextrin? A Preliminary Study

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 3,792 other subscribers
 

Loading Comments...